EHC - Encompass Health Corp Stock Price, Fair Value and News

85.32USD-0.56 (-0.65%)Market Closed

Market Summary

USD85.32-0.56

Market Closed

-0.65%

EHC Alerts

1 major insider buys and 2 major insider sales recently.

EHC Stock Price

View Fullscreen

EHC RSI Chart

EHC Valuation

Market Cap

8.6B

Price/Earnings (Trailing)

22.8

Price/Sales (Trailing)

1.73

EV/EBITDA

10.49

Price/Free Cashflow

9.97

EHC Price/Sales (Trailing)

EHC Profitability

EBT Margin

12.90%

Return on Equity

15.95%

Return on Assets

6.05%

Free Cashflow Yield

10.03%

EHC Fundamentals

EHC Revenue

Revenue (TTM)

5.0B

Rev. Growth (Yr)

13.41%

Rev. Growth (Qtr)

5.55%

EHC Earnings

Earnings (TTM)

376.8M

Earnings Growth (Yr)

28.28%

Earnings Growth (Qtr)

28.42%

Breaking Down EHC Revenue

Last 7 days

2.9%

Last 30 days

3.7%

Last 90 days

16.2%

Trailing 12 Months

38.8%

How does EHC drawdown profile look like?

EHC Financial Health

Current Ratio

1.37

Debt/Equity

1.14

Debt/Cashflow

0.32

EHC Investor Care

Dividend Yield

0.7%

Dividend/Share (TTM)

0.6

Shares Dilution (1Y)

0.45%

Diluted EPS (TTM)

3.7

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	5.0B	0	0	0
2023	4.4B	4.6B	4.7B	4.8B
2022	4.1B	4.2B	4.3B	4.3B
2021	4.4B	4.3B	4.2B	4.0B
2020	4.7B	4.6B	4.6B	4.6B
2019	4.4B	4.4B	4.5B	4.6B
2018	4.0B	4.1B	4.2B	4.3B
2017	3.8B	3.8B	3.9B	3.9B
2016	3.3B	3.5B	3.6B	3.7B
2015	2.6B	2.7B	2.9B	3.2B
2014	2.3B	2.3B	2.4B	2.4B
2013	2.2B	2.2B	2.3B	2.3B
2012	2.1B	2.1B	2.1B	2.2B
2011	1.9B	2.0B	2.0B	2.0B
2010	1.8B	1.8B	1.7B	1.9B
2009	0	1.8B	1.8B	1.8B
2008	0	0	0	1.8B

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Encompass Health Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
May 06, 2024	darby john patrick	sold	-1,220,740	83.94	-14,543	evp, gen counsel & secretary
May 06, 2024	darby john patrick	acquired	422,620	29.06	14,543	evp, gen counsel & secretary
May 03, 2024	carmichael greg d	bought	167,460	83.73	2,000	-
May 02, 2024	o'connor kevin j.	acquired	-	-	1,978	-
May 02, 2024	carmichael greg d	acquired	-	-	1,978	-
May 02, 2024	herman joan e	acquired	-	-	1,978	-
May 02, 2024	christie edward m iii	acquired	-	-	1,978	-
May 02, 2024	katz leslye g	acquired	-	-	1,978	-
May 02, 2024	reidy christopher r	acquired	-	-	1,978	-
May 02, 2024	maryland patricia anne	acquired	-	-	1,978	-

Which funds bought or sold EHC recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 07, 2024	M&T Bank Corp	unchanged	-	47,063	248,477	-%
May 07, 2024	NEW YORK STATE COMMON RETIREMENT FUND	reduced	-14.59	378,000	6,984,000	0.01%
May 07, 2024	OPPENHEIMER ASSET MANAGEMENT INC.	reduced	-1.89	399,648	2,264,670	0.03%
May 07, 2024	SEI INVESTMENTS CO	reduced	-4.28	3,155,380	20,228,200	0.03%
May 07, 2024	TECTONIC ADVISORS LLC	added	12.02	144,155	517,121	0.04%
May 07, 2024	ASSETMARK, INC	sold off	-100	-400	-	-%
May 07, 2024	SUSQUEHANNA INTERNATIONAL GROUP, LLP	added	67.09	3,287,240	6,364,770	-%
May 07, 2024	Swiss National Bank	added	0.15	3,157,120	16,334,300	0.01%
May 07, 2024	MEEDER ASSET MANAGEMENT INC	new	-	815,643	815,643	0.05%
May 07, 2024	OPPENHEIMER & CO INC	added	5.61	2,293,670	9,761,040	0.16%

Are Funds Buying or Selling EHC?

Are funds buying EHC calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own EHC

No. of Funds

EHC Alerts

1 major insider buys and 2 major insider sales recently.

Unveiling Encompass Health Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 12, 2024	william blair investment management, llc	5.2%	5,218,171	SC 13G
Feb 12, 2024	vanguard group inc	10.10%	10,120,689	SC 13G/A
Feb 12, 2024	vanguard group inc	9.97%	9,997,034	SC 13G/A
Feb 08, 2024	wellington management group llp	8.20%	8,215,770	SC 13G/A
Jan 24, 2024	blackrock inc.	9.1%	9,125,779	SC 13G/A
Feb 09, 2023	vanguard group inc	9.77%	9,749,441	SC 13G/A
Feb 06, 2023	wellington management group llp	9.58%	9,558,849	SC 13G/A
Jan 30, 2023	blackrock inc.	11.3%	11,232,620	SC 13G/A
Jan 30, 2023	blackrock inc.	11.3%	11,232,620	SC 13G/A
Feb 10, 2022	vanguard group inc	9.46%	9,414,569	SC 13G/A

Recent SEC filings of Encompass Health Corp

View All Filings

Date Filed	Form Type	Document
May 07, 2024	4	Insider Trading
May 07, 2024	4	Insider Trading
May 06, 2024	144	Notice of Insider Sale Intent
May 06, 2024	8-K	Current Report
May 03, 2024	4	Insider Trading
May 03, 2024	4	Insider Trading
May 03, 2024	4	Insider Trading
May 03, 2024	4	Insider Trading
May 03, 2024	4	Insider Trading
May 03, 2024	4	Insider Trading

Peers (Alternatives to Encompass Health Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	463.9B	371.6B	10.35%	2.61%	20.73	1.25	14.64%	11.24%
CI	98.7B	206.0B	-2.97%	32.18%	25.6	0.48	12.55%	-43.95%
HCA	81.0B	66.7B	-5.69%	12.88%	14.81	1.21	9.59%	-4.59%
CVS	68.9B	360.9B	-26.25%	-21.54%	9.41	0.19	9.07%	78.49%
CNC	40.5B	155.5B	3.95%	12.19%	14.8	0.26	6.34%	84.42%
DVA	11.9B	12.3B	1.61%	34.91%	14.61	0.97	5.77%	58.74%
UHS	11.7B	14.3B	-1.27%	18.38%	16.36	0.82	6.59%	6.24%
MID-CAP
CHE	8.6B	2.3B	-8.25%	4.64%	30.5	3.77	5.96%	18.29%
ACHC	6.1B	3.0B	-12.48%	-3.87%	-542.08	2.05	10.92%	-104.06%
AMN	2.3B	3.8B	2.67%	-35.23%	10.84	0.6	-27.73%	-52.50%
AMEH	2.1B	1.4B	-9.72%	19.70%	34.78	1.52	21.19%	34.42%
SMALL-CAP
ADUS	1.8B	1.1B	5.80%	29.14%	26.69	1.61	11.45%	30.74%
BKD	1.3B	3.0B	1.30%	77.47%	-7.02	0.44	6.74%	20.73%
BEAT	54.0M	-	-4.65%	-8.89%	-3.69	-	-	-12.94%
AMS	19.4M	21.3M	3.37%	9.25%	36.46	0.91	8.00%	-62.25%

Encompass Health Corp News

Latest updates

Encompass Health Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	5.6%	1,316	1,247	1,207	1,187	1,160	1,137	1,090	1,063	1,059	1,043	1,011	1,002	960	1,214	1,174	1,074	1,182	1,184	1,162	1,135	1,124
Costs and Expenses	4.9%	1,109	1,057	1,028	1,003	982	958	941	913	907	656	844	1,069	1,023	61.00	1,001	975	1,002	1,022	990	965	937
S&GA Expenses	-100.0%	-	53.00	50.00	55.00	43.00	43.00	38.00	36.00	37.00	42.00	39.00	54.00	39.00	34.00	39.00	43.00	36.00	64.00	53.00	77.00	53.00
EBITDA Margin	0.4%	0.21*	0.21*	0.21*	0.21*	0.20*	0.20*	0.18*	0.19*	0.21*	0.23*	0.21*	0.21*	-	-	-	-	-	-	-	-	-
Interest Expenses	0.9%	35.00	35.00	36.00	36.00	36.00	38.00	38.00	60.00	40.00	40.00	40.00	42.00	43.00	46.00	49.00	46.00	43.00	45.00	40.00	38.00	37.00
Income Taxes	3.0%	38.00	37.00	30.00	33.00	32.00	32.00	22.00	23.00	24.00	23.00	26.00	28.00	25.00	38.00	27.00	12.00	27.00	27.00	34.00	24.00	31.00
Earnings Before Taxes	8.3%	178	165	145	151	146	151	107	83.00	110	71.00	128	182	167	30.00	127	60.00	136	118	154	135	157
EBT Margin	2.0%	0.13*	0.13*	0.13*	0.12*	0.11*	0.10*	0.09*	0.09*	0.12*	0.14*	0.12*	0.12*	-	-	-	-	-	-	-	-	-
Net Income	28.4%	113	88.00	85.00	91.00	88.00	89.00	45.00	49.00	88.00	92.00	100	113	107	86.00	78.00	34.00	87.00	68.00	98.00	91.00	102
Net Income Margin	3.7%	0.08*	0.07*	0.08*	0.07*	0.06*	0.06*	0.06*	0.08*	0.10*	0.10*	0.10*	0.09*	-	-	-	-	-	-	-	-	-
Free Cashflow	18.8%	239	201	69.00	90.00	131	-17.70	-79.20	132	106	-68.50	58.00	142	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	2.1%	6,231	6,102	5,964	5,861	5,747	5,637	5,476	7,082	6,944	6,865	6,722	6,613	6,542	6,446	6,611	6,503	6,138	6,081	6,387	5,812	5,584
Current Assets	10.5%	930	842	814	824	762	717	734	1,032	950	921	910	859	1,001	949	1,174	1,102	785	756	1,077	845	683
Cash Equivalents	94.5%	134	69.00	100	118	85.00	22.00	60.00	136	77.00	49.00	66.00	73.00	224	186	450	419	105	60.00	422	222	56.00
Net PPE	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,095	2,041	2,003	1,959	1,875	1,788	1,736
Goodwill	0%	1,281	1,281	1,281	1,271	8.00	1,263	1,247	2,457	2,457	1,237	2,418	2,412	2,319	1,228	2,319	2,319	2,312	1,219	2,305	2,112	2,112
Liabilities	0.6%	3,828	3,805	3,775	3,804	3,784	3,775	3,728	4,538	4,452	4,466	4,428	4,404	4,468	4,444	4,681	4,638	4,307	4,148	4,506	3,876	3,694
Current Liabilities	3.6%	680	656	639	655	592	576	605	835	755	749	794	805	812	717	683	664	586	721	1,109	753	768
Long Term Debt	-0.2%	2,683	2,688	2,693	2,698	2,723	2,742	2,719	3,234	3,221	3,241	3,142	3,106	3,160	3,251	3,539	3,547	3,322	3,023	2,962	2,720	2,522
Shareholder's Equity	43.4%	2,362	1,648	1,560	2,018	1,926	1,310	1,710	2,501	2,448	2,357	2,261	2,176	2,043	1,970	1,896	1,831	1,797	1,693	1,671	1,584	1,617
Retained Earnings	-100.0%	-	407	-	-	-	116	-	-	-	142	-	-	-	-242	-	-	-	-526	-	-	-
Additional Paid-In Capital	-100.0%	-	1,787	-	-	-	1,730	-	-	-	2,290	-	-	-	2,327	-	-	-	2,370	-	-	-
Shares Outstanding	0.3%	100	100	100	100	99.00	99.00	99.00	99.00	99.00	99.00	99.00	99.00	-	-	-	-	-	-	-	-	-
Minority Interest	2.1%	620	608	587	542	542	516	493	498	475	446	418	414	388	382	375	369	353	341	338	308	302
Float	-	-	-	-	6,700	-	-	-	5,500	-	-	-	7,600	-	-	-	6,000	-	-	-	6,200	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	18.8%	238,800	201,000	215,200	206,700	227,900	172,200	70,100	244,600	218,900	123,800	177,600	255,900	158,500	279,700	173,400	222,300	29,300	215,600	114,400	145,400	159,900
Share Based Compensation	-30.6%	9,300	13,400	13,700	15,600	7,900	8,100	7,300	7,700	6,100	9,500	4,800	12,000	2,800	300	8,300	9,900	7,100	27,400	21,700	45,900	19,400
Cashflow From Investing	37.7%	-129,700	-208,100	-162,200	-128,500	-104,000	-206,400	-174,300	-123,200	-123,100	-220,700	-124,000	-226,000	-95,600	-142,700	-89,700	-92,100	-83,000	-145,700	-320,100	-100,100	-91,500
Cashflow From Financing	-35.8%	-40,600	-29,900	-65,800	-43,500	-58,000	-16,500	-49,000	-19,300	-60,900	42,300	-18,500	-186,400	-77,500	-354,200	-45,600	182,800	71,100	-424,100	431,800	122,200	-81,700
Dividend Payments	6.7%	15,900	14,900	15,000	14,900	15,600	14,900	27,800	27,800	28,500	27,700	27,600	27,800	29,100	27,500	27,600	27,700	29,000	27,400	26,400	26,600	28,300
Buy Backs	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,200	-	-	-	-	2,100	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

EHC Income Statement

2024-03-31

Condensed Consolidated Statements of Comprehensive Income - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Net operating revenues	$ 1,316.0	$ 1,160.4
Operating expenses:
Salaries and benefits	711.6	629.0
Other operating expenses	203.9	177.9
Occupancy costs	14.0	13.8
Supplies	58.5	53.8
General and administrative expenses	50.2	43.4
Depreciation and amortization	70.3	63.9
Total operating expenses	1,108.5	981.8
Interest expense and amortization of debt discounts and fees	35.2	36.4
Other income	(5.4)	(3.6)
Equity in net income of nonconsolidated affiliates	(0.7)	(0.4)
Income from continuing operations before income tax expense	178.4	146.2
Provision for income tax expense	38.3	31.9
Income from continuing operations	140.1	114.3
Loss from discontinued operations, net of tax	(1.3)	(1.0)
Net and comprehensive income	138.8	113.3
Net and comprehensive income	138.8	113.3
Less: Net and comprehensive income attributable to noncontrolling interests	(26.3)	(25.6)
Less: Net and comprehensive income attributable to noncontrolling interests	(26.3)	(25.6)
Net and comprehensive income attributable to Encompass Health	112.5	87.7
Net and comprehensive income attributable to Encompass Health	$ 112.5	$ 87.7
Weighted average common shares outstanding:
Basic (in shares)	99.8	99.4
Diluted (in shares)	102.2	100.9
Basic earnings per share attributable to Encompass Health common shareholders:
Continuing operations (in dollars per share)	$ 1.13	$ 0.89
Discontinued operations (in dollars per share)	(0.01)	(0.01)
Net income (in dollars per share)	1.12	0.88
Diluted earnings per share attributable to Encompass Health common shareholders:
Continuing operations (in dollars per share)	1.11	0.88
Discontinued operations (in dollars per share)	(0.01)	(0.01)
Net income (in dollars per share)	$ 1.10	$ 0.87
Amounts attributable to Encompass Health common shareholders:
Income from continuing operations	$ 113.8	$ 88.7
Loss from discontinued operations, net of tax	(1.3)	(1.0)
Net and comprehensive income attributable to Encompass Health	$ 112.5	$ 87.7

EHC Balance Sheet

2024-03-31

Condensed Consolidated Balance Sheets - USD ($)
$ in Millions

Mar. 31, 2024

Dec. 31, 2023

Current assets:

Cash and cash equivalents

$ 134.4

$ 69.1

Restricted cash

38.3

35.1

Accounts receivable

619.3

611.6

Other current assets

137.8

126.0

Total current assets

929.8

841.8

Property and equipment, net

3,370.3

3,301.0

Operating lease right-of-use assets

199.1

208.5

Goodwill

1,281.3

Intangible assets, net

272.2

278.2

Other long-term assets

178.7

191.6

Total assets

^[1]

6,231.4

6,102.4

Current liabilities:

Current portion of long-term debt

25.6

24.8

Current operating lease liabilities

25.4

24.1

Accounts payable

166.1

170.0

Accrued expenses and other current liabilities

463.2

437.5

Total current liabilities

680.3

656.4

Long-term debt, net of current portion

2,682.6

2,687.8

Long-term operating lease liabilities

185.8

196.1

Deferred income tax liabilities

93.5

87.0

Other long-term liabilities

185.8

177.9

Total liabilities

3,828.0

3,805.2

Commitments and contingencies

Redeemable noncontrolling interests

41.1

42.0

Shareholders’ equity:

Encompass Health shareholders’ equity

1,741.9

1,647.5

Noncontrolling interests

620.4

607.7

Total shareholders’ equity

2,362.3

2,255.2

Total liabilities and shareholders' equity

^[1]

$ 6,231.4

$ 6,102.4

[1]

Our consolidated assets as of March 31, 2024 and December 31, 2023 include total assets of variable interest entities of $212.7 million and $207.7 million, respectively, which cannot be used by us to settle the obligations of other entities. Our consolidated liabilities as of March 31, 2024 and December 31, 2023 include total liabilities of the variable interest entities of $42.7 million and $42.2 million, respectively. See Note 2, Variable Interest Entities.

About Encompass Health Corp

Encompass Health Corporation provides post-acute healthcare services in the United States. It provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides services under the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.

CEO	Mr. Mark J. Tarr
WEBSITE	encompasshealth.com
INDUSTRY	Healthcare Plans
EMPLOYEES	36900

Encompass Health Corp Frequently Asked Questions

What is the ticker symbol for Encompass Health Corp? What does EHC stand for in stocks?

EHC is the stock ticker symbol of Encompass Health Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Encompass Health Corp (EHC)?

As of Wed May 08 2024, market cap of Encompass Health Corp is 8.59 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of EHC stock?

You can check EHC's fair value in chart for subscribers.

What is the fair value of EHC stock?

You can check EHC's fair value in chart for subscribers. The fair value of Encompass Health Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Encompass Health Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for EHC so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Encompass Health Corp a good stock to buy?

The fair value guage provides a quick view whether EHC is over valued or under valued. Whether Encompass Health Corp is cheap or expensive depends on the assumptions which impact Encompass Health Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for EHC.

What is Encompass Health Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed May 08 2024, EHC's PE ratio (Price to Earnings) is 22.8 and Price to Sales (PS) ratio is 1.73. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. EHC PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Encompass Health Corp's stock?

In the past 10 years, Encompass Health Corp has provided 0.141 (multiply by 100 for percentage) rate of return.